Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588) Meeting Abstract

cited authors

  • Holloway, R. W.; Mendivil, A. A.; Kendrick, J. E.; Abaid, L. N.; Brown, J. V.; Fitzsimmons, C. K.; Kennard, J. A.; King, M.; LeBlanc, J.; Lopez, K.; Manyam, M.; McKenzie, N. D.; Mori, K. M.; Stephens, A. J.; Ahmad, S.

Publication Date

  • September 1, 2020

webpage

published in

category

start page

  • S628

end page

  • S628

volume

  • 31